Lisa H Butterfield Selected Research

Tumor Biomarkers (Tumor Markers)

1/2023	Polyunsaturated Fatty Acid-Bound α-Fetoprotein Promotes Immune Suppression by Altering Human Dendritic Cell Metabolism.
12/2018	SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa H Butterfield Research Topics

Disease

109	Neoplasms (Cancer) 02/2024 - 02/2002
52	Melanoma (Melanoma, Malignant) 11/2023 - 11/2002
13	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2002
12	Glioma (Gliomas) 01/2023 - 12/2007
11	Liver Neoplasms (Liver Cancer) 01/2023 - 02/2002
4	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2014
3	Brain Neoplasms (Brain Tumor) 01/2023 - 12/2020
3	Fatigue 01/2020 - 05/2010
3	Squamous Cell Carcinoma of Head and Neck 04/2017 - 06/2012
2	Testicular Neoplasms (Testicular Cancer) 01/2018 - 01/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 04/2017 - 05/2014
2	Carcinoma (Carcinomatosis) 01/2016 - 05/2010
2	Colitis 01/2015 - 01/2014
2	Diarrhea 01/2015 - 01/2014
2	Pain (Aches) 06/2011 - 05/2010
2	Experimental Melanoma 04/2011 - 06/2005
2	Hepatitis B 02/2007 - 11/2004
1	Adenocarcinoma 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Vascular Tissue Neoplasms 11/2021
1	Diffuse Intrinsic Pontine Glioma 12/2020
1	Tertiary Lymphoid Structures 01/2020
1	COVID-19 01/2020

Drug/Important Bio-Agent (IBA)

45	AntigensIBA 01/2022 - 07/2002
40	VaccinesIBA 11/2023 - 11/2002
30	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2003
27	Peptides (Polypeptides)IBA 11/2021 - 07/2002
18	CytokinesIBA 01/2020 - 11/2004
17	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2002
15	EpitopesIBA 12/2016 - 03/2003
14	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2019 - 12/2003
12	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 06/2003
10	Cancer VaccinesIBA 11/2023 - 10/2007
10	InterferonsIBA 11/2021 - 12/2007
9	IpilimumabIBA 01/2022 - 09/2012
6	Fetal Proteins (Fetoprotein)IBA 01/2023 - 07/2011
6	Protein Subunit VaccinesIBA 01/2018 - 02/2009
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2017 - 08/2012
6	HLA-A*02:01 antigenIBA 01/2014 - 03/2003
4	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2017
4	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021 - 12/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 10/2011
4	gallium arsenide (GaAs)IBA 12/2016 - 12/2007
3	EnzymesIBA 11/2021 - 12/2007
3	Interleukin-2 (IL2)IBA 01/2020 - 07/2008
3	InterleukinsIBA 01/2019 - 12/2007
3	ChemokinesIBA 01/2019 - 10/2011
3	MART-1 AntigenIBA 01/2016 - 09/2003
3	poly ICLCIBA 01/2016 - 01/2011
3	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 06/2003
3	AutoantigensIBA 01/2014 - 02/2002
3	Monophenol Monooxygenase (Tyrosinase)IBA 08/2012 - 04/2008
2	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 12/2018
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2016
2	Programmed Cell Death 1 ReceptorIBA 11/2021 - 01/2017
2	B7-H1 AntigenIBA 01/2021 - 01/2017
2	pembrolizumabIBA 01/2021 - 11/2017
2	LigandsIBA 12/2020 - 11/2018
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2019 - 06/2003
2	Monatide (IMS 3015)IBA 09/2017 - 11/2004
2	Interleukin-10 (Interleukin 10)IBA 01/2015 - 12/2004
2	Carboxymethylcellulose Sodium (Polycell)FDA Link 07/2014 - 01/2011
2	Lysine (L-Lysine)FDA Link 07/2014 - 01/2011
2	Poly I-CIBA 07/2014 - 01/2011
2	HLA-DR Antigens (HLA-DR)IBA 01/2014 - 01/2014
2	Interleukin-12 (IL 12)IBA 04/2011 - 11/2002
2	Viral AntigensIBA 02/2007 - 11/2004
1	trametinibIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	dabrafenibIBA 01/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	Interferon-alpha (Interferon Alfa)IBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	NivolumabIBA 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Adapalene (Differin)FDA LinkGeneric 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	sotigalimabIBA 01/2022
1	LipidsIBA 01/2022
1	Dasatinib (BMS 354825)FDA Link 11/2021
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	ImmunosorbentsIBA 11/2021
1	dipinacoline glutamateIBA 12/2020
1	Matrix Metalloproteinases (MMPs)IBA 12/2020
1	AntibodiesIBA 01/2020
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2019
1	Viral DNAIBA 01/2019

Therapy/Procedure

62	Immunotherapy 01/2023 - 02/2002
34	Therapeutics 02/2024 - 08/2004
5	Drug Therapy (Chemotherapy) 01/2022 - 10/2013
5	Biological Therapy 09/2011 - 12/2008
3	Injections 04/2014 - 08/2004
2	Radiotherapy 01/2015 - 12/2007
2	Neoadjuvant Therapy 01/2015 - 06/2012
2	Complementary Therapies (Alternative Medicine) 02/2007 - 11/2004